Given the Weizmann Institute’s worldwide renown for discoveries and insights in immunology, and how the immune system identifies pathogens and overcomes them—or fails to overcome them—our scientists are uniquely positioned to advance understanding and chart new paths forward amidst the coronavirus pandemic.
In one highly promising project, our scientists are using computational and experimental tools to rapidly design antibodies that will target the SPIKE protein in the coronavirus and thereby neutralize infection. Another scientist is applying new insights from another set of animal-borne viruses to COVID-19. And others are exploring the intricate mechanisms of the immune system and ways in which our healthy cells mount counter-attacks to deadly viruses.
our latest research in these areas
-
Towards a drug against COVID-19
Co-led by Dr. Nir London, global consortium aims to accelerate drug development - Designing a solution
Computational approach may lead to a future treatment for coronavirus - How do viruses infect?
Deciphering the dynamic that hijacks our health - New weapon in the war on animal-borne viruses
Engineered molecule could lead to treatments for viruses that cross over from animals to humans - Learning from lethal viruses
Insights on Ebola, arenaviruses pave way for Dr. Ron Diskin's next target—coronavirus
